Alkami price target raised to $22 from $18 at Citi

Citi raised the firm’s price target on Alkami to $22 from $18 and keeps a Buy rating on the shares. The company’s Q4 results and forward outlook illustrated good execution and demand, the analyst tells investors in a research note. The firm likes Alkami’s revenue growth visibility in an uncertain environment.